Antimicrobial resistance in Shiga toxin-producing Escherichia coli serogroups O157 and O26 isolated from human cases of diarrhoeal disease in England, 2015

Journal of Antimicrobial Chemotherapy

Volumn 72, Issue 1, 2017, Pages 145-152

  Day, Martin ^a   Doumith, Michel ^a   Jenkins, Claire ^a   Dallman, Timothy J ^a   Hopkins, Katie L ^a   Elson, Richard ^a   Godbole, Gauri ^a   Woodford, Neil ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMPICILLIN; AZITHROMYCIN; BETA LACTAM ANTIBIOTIC; CHLORAMPHENICOL; CIPROFLOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; QUINOLONE DERIVATIVE; STREPTOMYCIN; SULFAMETHOXAZOLE; TETRACYCLINE; TETRACYCLINE DERIVATIVE; ANTIINFECTIVE AGENT;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; DIARRHEA; ENGLAND; GENE EXPRESSION; GENETIC RESISTANCE; HUMAN; NONHUMAN; SEROTYPE; SHIGA TOXIN PRODUCING ESCHERICHIA COLI; ANIMAL; BACTERIAL GENOME; DISEASE TRANSMISSION; DNA SEQUENCE; DRUG EFFECTS; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; GENETICS; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; PREVALENCE; TRANSMISSION; ZOONOSES;

ANIMALS; ANTI-BACTERIAL AGENTS; DIARRHEA; DISEASE TRANSMISSION, INFECTIOUS; DRUG RESISTANCE, BACTERIAL; ENGLAND; ESCHERICHIA COLI INFECTIONS; ESCHERICHIA COLI O157; GENOME, BACTERIAL; HUMANS; MICROBIAL SENSITIVITY TESTS; PREVALENCE; SEQUENCE ANALYSIS, DNA; ZOONOSES;

EID: 85014516462     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkw371     Document Type: Article

References (38)

1. Cheney TE, Smith RP, Hutchinson JP et al. Cross-sectional survey of antibiotic resistance in Escherichia coli isolated from diseased farm livestock in England and Wales. Epidemiol Infect 2015; 143: 2653-9.
2. European Food Safety Authority (EFSA). The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2014. EFSA Journal 2016; 14: doi:10.2903/j.efsa.2016.4380.
3. Woodford N, Turton JF, Livermore DM. Multiresistant Gram-negative bacteria: the role of high-risk clones in the dissemination of antibiotic resistance. FEMS Microbiol Rev 2011; 35: 736-55.
4. Naylor SW, Gally DL, Low JC. Enterohaemorrhagic E. coli in veterinary medicine. Int J Med Microbiol 2005; 295: 419-41.
5. Byrne L, Jenkins C, Launders N et al. The epidemiology, microbiology and clinical impact of Shiga toxin-producing Escherichia coli in England, 2009-2012. Epidemiol Infect 2015; 143: 3475-87.
6. Byrne L, Vanstone GL, Perry NT et al. Epidemiology and microbiology of Shiga toxin-producing Escherichia coli other than serogroup O157 in England, 2009-2013. J Med Microbiol 2014; 63: 1181-8.
7. Jenkins C, Lawson AJ, Cheasty T et al. Assessment of a real-time PCR for the detection and characterization of verocytotoxigenic Escherichia coli. J Med Microbiol 2012; 61: 1082-5.
8. Dallman TJ, Byrne L, Ashton PM et al. Whole-genome sequencing for national surveillance of Shiga toxin-producing Escherichia coli O157. Clin Infect Dis 2015; 61: 305-12.
9. Chattaway MA, Dallman TJ, Gentle A et al. Whole genome sequencing for public health surveillance of Shiga toxin-producing Escherichia coli other than serogroup O157. Front Microbiol 2016; 7: 258.
10. Stoesser N, Batty EM, Eyre DWet al. Predicting antimicrobial susceptibilities for Escherichia coli and Klebsiella pneumoniae isolates using whole genomic sequence data. J Antimicrob Chemother 2013; 68: 2234-44.
11. Zankari E, Hasman H, Kaas RS et al. Genotyping using whole-genome sequencing is a realistic alternative to surveillance based on phenotypic antimicrobial susceptibility testing. J Antimicrob Chemother 2013; 68: 771-7.
12. Tyson GH, McDermott PF, Li C et al. WGS accurately predicts antimicrobial resistance in Escherichia coli. J Antimicrob Chemother 2015; 70: 2763-9.
13. Dallman TJ, Ashton PM, Byrne L et al. Applying phylogenomics to understand the emergence of Shiga-toxin-producing Escherichia coli O157:H7 strains causing severe human disease in the UK. Microb Genom 2015; doi:10.1099/mgen.0.000029.
14. Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods 2012; 9: 357-9.
15. Magiorakos A-P, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012; 18: 268-81.
16. Vidovic S, Tsoi S, Medihala P et al. Molecular and antimicrobial susceptibility analyses distinguish clinical from bovine Escherichia coli O157 strains. J Clin Microbiol 2013; 51: 2082-8.
17. Zhao S, White DG, Ge B et al. Identification and characterization of integron-mediated antibiotic resistance among Shiga toxin-producing Escherichia coli isolates. Appl Environ Microbiol 2001; 67: 1558-64.
18. Mora A, Blanco JE, Blanco M et al. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain. Res Microbiol 2005; 156: 793-806.
19. Aslam M, Stanford K, McAllister TA. Characterization of antimicrobial resistance and seasonal prevalence of Escherichia coli O157:H7 recovered from commercial feedlots in Alberta, Canada. Lett Appl Microbiol 2010; 50: 320-6.
20. Ziebell K, Johnson RP, Kropinski AM et al. Gene cluster conferring streptomycin, sulfonamide, and tetracycline resistance in Escherichia coli O157:H7 phage types 23, 45, and 67. Appl Environ Microbiol 2011; 77: 1900-3.
21. Wang J, Stanford K, McAllister TA et al. Biofilm formation, virulence gene profiles, and antimicrobial resistance of nine serogroups of non-O157 Shiga toxin-producing Escherichia coli. Foodborne Pathog Dis 2016; 13: 316-24.
22. Krüger A, Lucchesi PM, Sanso AM et al. Genetic characterization of Shiga toxin-producing Escherichia coli O26:H11 strains isolated from animal, food, and clinical samples. Front Cell Infect Microbiol 2015; 5: 74.
23. Willshaw GA, Cheasty T, Smith HR et al. Verocytotoxin-producing Escherichia coli (VTEC) O157 and other VTEC from human infections in England and Wales: 1995-1998. J Med Microbiol 2001; 50: 135-42.
24. Threlfall EJ, Ward LR, Frost JA et al. The emergence and spread of antibiotic resistance in food-borne bacteria. Int J Food Microbiol 2000; 62: 1-5.
25. Valat C, Haenni M, Saras E et al. CTX-M-15 extended-spectrum β-lactamase in a Shiga toxin-producing Escherichia coli isolate of serotype O111:H8. Appl Environ Microbiol 2012; 78: 1308-9.
26. Mellmann A, Harmsen D, Cummings CA et al. Prospective genomic characterization of the German enterohemorrhagic Escherichia coli O104:H4 outbreak by rapid next generation sequencing technology. PLoS One 2011; 6: e22751.
27. Ahmed AM, Shimamoto T. Molecular analysis of multidrug resistance in Shiga toxin-producing Escherichia coli O157:H7 isolated from meat and dairy products. Intern J Food Microbiol 2015; 193: 68-73.
28. Guardabassi l, Jensen LB, Kruse H (eds). Guide to Antimicrobial Use in Animals. Ames, IA: Blackwell Publishing, 2008.
29. Johnson JR, Kuskowski MA, Smith K et al. Antimicrobial resistant and extraintestinal pathogenic Escherichia coli in retail foods. J Infect Dis 2005; 191: 1040-9.
30. Zhao S, BlickenstaffK, Bodeis-Jones S et al. Comparison of the prevalences and antimicrobial resistances of Escherichia coli isolates from different retail meats in the United States, 2002 to 2008. Appl Environ Microbiol 2012; 78: 1701-7.
31. Doumith M, Godbole G, Ashton P et al. Detection of the plasmidmediated mcr-1 gene conferring colistin resistance in human and food isolates of Salmonella enterica and Escherichia coli in England and Wales. J Antimicrob Chemother 2016; 71: 2300-5.
32. Liu YY, Wang Y, Walsh TR et al. Emergence of plasmid-mediated colistin resistance mechanism MCR-1 in animals and human beings in China: a microbiological and molecular biological study. Lancet Infect Dis 2016; 16: 161-8.
33. Skov RL, Monnet DL. Plasmid-mediated colistin resistance (mcr-1 gene): three months later, the story unfolds. Euro Surveill 2016; 21: pii=30155.
34. Yu X, Susa M, Knabbe C et al. Development and validation of a diagnostic DNA microarray to detect quinolone-resistant Escherichia coli among clinical isolates. J Clin Microbiol 2004; 42: 4083-91.
35. Michael M, Elliott EJ, Ridley GF et al. Interventions for haemolytic uraemic syndrome and thrombotic thrombocytopenic purpura. Cochrane Database Syst Rev 2009; issue 1: CD003595.
36. Taylor CM, Machin S, Wigmor S et al. on behalf of the Renal Association, the British Committee for Standards in Haematology and the British Transplantation Society. Clinical Practice Guidelines for the Management of Atypical Haemolytic Uraemic Syndrome in the United Kingdom. 2009; 1-22. http://www.renal.org/guidelines/joint-guidelines#sthash. 29lIW8fO.dpbs.
37. Wong CS, Jelacic S, Habeeb RL et al. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections. N Engl J Med 2000; 342: 1930-6.
38. Baker KS, Dallman TJ, Ashton PM et al. Intercontinental dissemination of azithromycin-resistant shigellosis through sexual transmission: a crosssectional study. Lancet Infect Dis 2015; 15: 913-21.